title: A new dawn in cardio and vascular protection v. cardiovascular high-risk patients: treat to protect.
authors.affiliation: Department of Nephrology and Endocrinology, University of Tokyo School of Medicine, Tokyo, Japan. fujita-dis@h.u-tokyo.ac.jp
authors.forename: Toshiro
authors.initials: T
authors.lastname: Fujita
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Mancia
authors.forename: Anne
authors.initials: A
authors.lastname: Jakobsen
authors.forename: Jose
authors.initials: J
authors.lastname: Heroys
authors.forename: Ann
authors.initials: A
authors.lastname: Ralph
authors.forename: Tomas
authors.initials: T
authors.lastname: Rees
authors.forename: Michael
authors.initials: M
authors.lastname: Shaw
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans; D011322:Primary Prevention / Q000639:trends*; D012307:Risk Factors
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D002316:Cardiotonic Agents